Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 100 publications
Multiple Chapters, One Career: Using Career Development Plans to Find Success and Satisfaction in Academic Oncology Across the Career Spectrum.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 25, 2026
Targeting ALC1 can safely expand the therapeutic utility of PARP inhibitors across high-grade serous ovarian cancers.
Journal: bioRxiv : the preprint server for biology
Published: December 19, 2025
Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2-deficient ovarian cancer model.
Journal: bioRxiv : the preprint server for biology
Published: October 03, 2025
MECOM amplified endometrial cancer, a novel subset of copy number high tumors associated with poor prognosis.
Journal: Gynecologic oncology reports
Published: October 01, 2025
Phase I De-escalated RT in Endometrial Cancer.
Journal: International journal of radiation oncology, biology, physics
Published: August 19, 2025
Phase I Clinical Trial of De-escalated Conformal Radiation Expedited Sequentially with Chemotherapy for Advanced Endometrial Cancer (DeCRESCEndo).
Journal: International journal of radiation oncology, biology, physics
Published: August 19, 2025
Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms.
Journal: bioRxiv : the preprint server for biology
Published: August 13, 2025
Association of Tumor-Infiltrating Lymphocytes and Inflammation Status with Survival Outcome in Patients with High-Grade Serous Ovarian Carcinoma.
Journal: Cancers
Published: May 26, 2025
Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Journal: bioRxiv : the preprint server for biology
Published: December 09, 2024
Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer.
Journal: The Journal of clinical investigation
Published: November 21, 2024
Last Updated: 09/26/2026